ATE209207T1 - Androgen rezeptor modulator verbindungen und verfahren - Google Patents
Androgen rezeptor modulator verbindungen und verfahrenInfo
- Publication number
- ATE209207T1 ATE209207T1 AT97931460T AT97931460T ATE209207T1 AT E209207 T1 ATE209207 T1 AT E209207T1 AT 97931460 T AT97931460 T AT 97931460T AT 97931460 T AT97931460 T AT 97931460T AT E209207 T1 ATE209207 T1 AT E209207T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- androgen receptor
- methods
- receptor modulator
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Endocrinology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Electrotherapy Devices (AREA)
- Steroid Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US2199796P | 1996-06-27 | 1996-06-27 | |
PCT/US1997/011222 WO1997049709A1 (en) | 1996-06-27 | 1997-06-26 | Androgen receptor modulator compounds and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE209207T1 true ATE209207T1 (de) | 2001-12-15 |
Family
ID=21807289
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97931460T ATE209207T1 (de) | 1996-06-27 | 1997-06-26 | Androgen rezeptor modulator verbindungen und verfahren |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0918774B9 (de) |
JP (1) | JP2000513362A (de) |
AT (1) | ATE209207T1 (de) |
AU (1) | AU728178B2 (de) |
BR (1) | BR9710988A (de) |
DE (1) | DE69709752T2 (de) |
DK (1) | DK0918774T3 (de) |
ES (1) | ES2168650T3 (de) |
NO (1) | NO311645B1 (de) |
PT (1) | PT918774E (de) |
RU (1) | RU2214412C2 (de) |
WO (1) | WO1997049709A1 (de) |
Families Citing this family (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6636733B1 (en) | 1997-09-19 | 2003-10-21 | Thompson Trust | Wireless messaging method |
US7003304B1 (en) | 1997-09-19 | 2006-02-21 | Thompson Investment Group, Llc | Paging transceivers and methods for selectively retrieving messages |
US6253061B1 (en) | 1997-09-19 | 2001-06-26 | Richard J. Helferich | Systems and methods for delivering information to a transmitting and receiving device |
US6826407B1 (en) | 1999-03-29 | 2004-11-30 | Richard J. Helferich | System and method for integrating audio and visual messaging |
US6983138B1 (en) | 1997-12-12 | 2006-01-03 | Richard J. Helferich | User interface for message access |
US6472415B1 (en) * | 1998-12-18 | 2002-10-29 | Biophysica, Inc. | Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
US6566372B1 (en) | 1999-08-27 | 2003-05-20 | Ligand Pharmaceuticals Incorporated | Bicyclic androgen and progesterone receptor modulator compounds and methods |
BR0013597A (pt) * | 1999-08-27 | 2002-07-16 | Ligand Pharm Inc | Compostos e métodos moduladores de receptor de androgênio |
WO2001016133A2 (en) * | 1999-08-27 | 2001-03-08 | Ligand Pharmaceuticals Incorporated | 8-substituted-6-trifluoromethyl-9-pyrido[3,2-g]quinoline compounds as androgen receptor modulators |
JP2003529545A (ja) | 1999-09-14 | 2003-10-07 | リガンド・ファーマシューティカルズ・インコーポレイテッド | 改善された薬理学的プロファイルを有するrxrモジュレーター |
WO2001023405A2 (en) | 1999-09-30 | 2001-04-05 | Hollis-Eden Pharmaceuticals, Inc. | Therapeutic treatment of androgen receptor driven conditions |
US20030175817A1 (en) * | 2000-02-10 | 2003-09-18 | Kyoji Ikeda | Method of screening for antiandrogen agent |
NZ523802A (en) * | 2000-06-28 | 2005-11-25 | Bristol Myers Squibb Co | Fused cyclic compounds as modulators of nuclear hormone receptor function |
JP3908162B2 (ja) | 2000-06-30 | 2007-04-25 | 中外製薬株式会社 | 新規な抗アンドロゲン剤 |
IL155019A0 (en) * | 2000-09-19 | 2003-10-31 | Bristol Myers Squibb Co | Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
US7214690B2 (en) | 2001-02-23 | 2007-05-08 | Ligand Pharmaceuticals Incorporated | Tricyclic quinolinone and tricyclic quinoline androgen receptor modulator compounds and methods |
US7026484B2 (en) | 2001-02-23 | 2006-04-11 | Ligand Pharmaceuticals Incorporated | Tricyclic androgen receptor modulator compounds and methods |
EP1439841B1 (de) * | 2001-10-19 | 2007-09-19 | Merck & Co., Inc. | Androgen-rezeptor-modulatoren und verwendungsverfahren dafür |
AU2002367424A1 (en) * | 2001-12-28 | 2003-07-24 | Takeda Chemical Industries, Ltd. | Androgen receptor antagonists |
US7705182B2 (en) | 2002-02-28 | 2010-04-27 | University Of Tennessee Research Foundation | Multi-substituted selective androgen receptor modulators and methods of use thereof |
WO2003090672A2 (en) * | 2002-04-26 | 2003-11-06 | Ortho-Mcneil Pharmaceutical, Inc. | 2-(quinolonyl)-fused heterocycles as androgen receptor modulators |
US7405234B2 (en) | 2002-05-17 | 2008-07-29 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
DE20301728U1 (de) | 2002-10-11 | 2004-03-11 | Ligand Pharmaceuticals, Inc., San Diego | 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen |
WO2004045518A2 (en) | 2002-11-15 | 2004-06-03 | Bristol-Myers Squibb Company | Open chain prolyl urea-related modulators of androgen receptor function |
CA2511089A1 (en) * | 2003-01-17 | 2004-08-05 | Warner-Lambert Company Llc | Androgen receptor antagonists |
MXPA06001751A (es) | 2003-08-22 | 2006-05-12 | Ligand Pharm Inc | Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno. |
US7256208B2 (en) | 2003-11-13 | 2007-08-14 | Bristol-Myers Squibb Company | Monocyclic N-Aryl hydantoin modulators of androgen receptor function |
US7820702B2 (en) | 2004-02-04 | 2010-10-26 | Bristol-Myers Squibb Company | Sulfonylpyrrolidine modulators of androgen receptor function and method |
US7388027B2 (en) | 2004-03-04 | 2008-06-17 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
US7696241B2 (en) | 2004-03-04 | 2010-04-13 | Bristol-Myers Squibb Company | Bicyclic compounds as modulators of androgen receptor function and method |
US7625923B2 (en) | 2004-03-04 | 2009-12-01 | Bristol-Myers Squibb Company | Bicyclic modulators of androgen receptor function |
WO2005090282A1 (en) | 2004-03-12 | 2005-09-29 | Ligand Pharmaceuticals Incorporated | Androgen receptor modulator compounds and methods |
JP5230448B2 (ja) * | 2006-02-10 | 2013-07-10 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 選択的アンドローゲン受容体モジュレーターとして有用な新イミダゾロピラゾール誘導体 |
US8067448B2 (en) | 2008-02-22 | 2011-11-29 | Radius Health, Inc. | Selective androgen receptor modulators |
US8268872B2 (en) | 2008-02-22 | 2012-09-18 | Radius Health, Inc. | Selective androgen receptor modulators |
EP2130831A1 (de) | 2008-06-06 | 2009-12-09 | InterMed Discovery GmbH | CDC25-Hemmer |
NZ596060A (en) * | 2009-04-30 | 2012-12-21 | Nissan Chemical Ind Ltd | NOVEL CRYSTAL FORMS OF TRICYCLIC BENZOPYRAN COMPOUND AND PROCESSES FOR PRODUCING SAME; (3R,4S)-7-hydroxymethyl-2,2,9-trimethyl-4-(phenethylamino)-3,4-dihydro-2H-pyrano[2,3g]quinolin-3-ol |
AU2011212813B2 (en) | 2010-02-04 | 2014-10-23 | Radius Health, Inc. | Selective androgen receptor modulators |
WO2011143469A1 (en) | 2010-05-12 | 2011-11-17 | Radius Health,Inc | Therapeutic regimens |
US8642632B2 (en) | 2010-07-02 | 2014-02-04 | Radius Health, Inc. | Selective androgen receptor modulators |
WO2012047617A1 (en) | 2010-09-28 | 2012-04-12 | Radius Health, Inc. | Selective androgen receptor modulators |
US8846006B2 (en) | 2011-01-20 | 2014-09-30 | Board Of Regents, The University Of Texas System | MRI markers, delivery and extraction systems, and methods of manufacture and use thereof |
US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
EP3122426B1 (de) | 2014-03-28 | 2023-01-18 | Duke University | Brustkrebsbehandlung mit selektiven östrogenrezeptormodulatoren |
IL292659A (en) | 2016-06-22 | 2022-07-01 | Ellipses Pharma Ltd | Methods for treating breast cancer ar plus |
CN106397317B (zh) * | 2016-09-26 | 2019-03-22 | 天津师范大学 | 1,2,3,4-四氢喹啉化合物及其合成方法与应用 |
CN106565723B (zh) * | 2016-11-04 | 2019-08-27 | 江苏师范大学 | 一种呋喃并吡啶、苯并吡啶类衍生化合物的制备方法 |
KR102557321B1 (ko) | 2017-01-05 | 2023-07-18 | 래디어스 파마슈티컬스, 인코포레이티드 | Rad1901-2hcl의 다형 형태 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0181264B1 (ko) * | 1989-07-07 | 1999-03-20 | 라브리 페르낭 | 성스테로이드 활성 억제용 안드로겐 유도체 |
US5677336A (en) * | 1993-10-21 | 1997-10-14 | Ligand Pharmaceuticals Incorporated | Non-steroid androgen receptor antagonist compounds and methods |
HUT78117A (hu) * | 1994-12-22 | 1999-11-29 | Ligand Pharmaceuticals Incorporated | Szteroid receptor modulátor kinolin- és kondenzált kinolinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények |
-
1997
- 1997-06-26 ES ES97931460T patent/ES2168650T3/es not_active Expired - Lifetime
- 1997-06-26 EP EP97931460A patent/EP0918774B9/de not_active Expired - Lifetime
- 1997-06-26 DK DK97931460T patent/DK0918774T3/da active
- 1997-06-26 WO PCT/US1997/011222 patent/WO1997049709A1/en active IP Right Grant
- 1997-06-26 AU AU35084/97A patent/AU728178B2/en not_active Ceased
- 1997-06-26 AT AT97931460T patent/ATE209207T1/de not_active IP Right Cessation
- 1997-06-26 PT PT97931460T patent/PT918774E/pt unknown
- 1997-06-26 RU RU99101057/04A patent/RU2214412C2/ru not_active IP Right Cessation
- 1997-06-26 JP JP10503562A patent/JP2000513362A/ja not_active Ceased
- 1997-06-26 BR BR9710988-6A patent/BR9710988A/pt not_active IP Right Cessation
- 1997-06-26 DE DE69709752T patent/DE69709752T2/de not_active Expired - Fee Related
-
1998
- 1998-12-23 NO NO19986100A patent/NO311645B1/no unknown
Also Published As
Publication number | Publication date |
---|---|
DE69709752T2 (de) | 2002-07-18 |
NO311645B1 (no) | 2001-12-27 |
DK0918774T3 (da) | 2002-05-21 |
NO986100L (no) | 1998-12-23 |
DE69709752D1 (de) | 2002-02-21 |
EP0918774A1 (de) | 1999-06-02 |
AU3508497A (en) | 1998-01-14 |
EP0918774B9 (de) | 2002-04-10 |
PT918774E (pt) | 2002-05-31 |
RU2214412C2 (ru) | 2003-10-20 |
AU728178B2 (en) | 2001-01-04 |
WO1997049709A1 (en) | 1997-12-31 |
BR9710988A (pt) | 2002-01-15 |
NO986100D0 (no) | 1998-12-23 |
ES2168650T3 (es) | 2002-06-16 |
JP2000513362A (ja) | 2000-10-10 |
EP0918774B1 (de) | 2001-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE209207T1 (de) | Androgen rezeptor modulator verbindungen und verfahren | |
DE69533180D1 (de) | Steroidrezeptor-Modulator Verbindungen und Methoden | |
MX9704640A (es) | Compuesto moduladores de los receptores de los esteroides y metodos para su preparacion. | |
WO2000066590A3 (en) | Tetracyclic progesterone receptor modulator compounds and methods | |
MY129189A (en) | Prostaglandin agonists and their use to treat bone disorders | |
YU7797A (sh) | Kombinovana terapija za osteoporozu | |
DK0873295T3 (da) | Dimer-selektive RXR-modulatorer og fremgangsmåder til deres anvendelse | |
YU38801A (sh) | Azabicikloalkani kao modulatori ccr5 | |
DE69728585D1 (de) | Mittel gegen Juckreiz | |
EP0911321A3 (de) | Verbindungen zur Behandlung von Osteoporose | |
DE69531403D1 (de) | Allosterische modulatoren des nmda-rezeptors | |
AP9801269A0 (en) | Prostaglandin agonists. | |
EA199900912A1 (ru) | Фармацевтические средства | |
BR9708347A (pt) | Compostos de tetrahidorbeta-carbonila | |
DK0996435T3 (da) | Aminosyrederivater anvendelige til behandling af slagtilfælde | |
DE59809283D1 (de) | Inhibitoren für den urokinaserezeptor | |
BR0206844A (pt) | Uso de antagonistas do receptor gal3 para o tratamento de depressão e/ou ansiedade e compostos usados em tais métodos | |
CA2259031A1 (en) | Androgen receptor modulator compounds and methods |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |